Journal article · 2022 · Open access
Genuine selective caspase-2 inhibition with new irreversible small peptidomimetics
Cell Death and Disease, 13(11), 959 · Published 15 November 2022 · DOI 10.1038/s41419-022-05396-2
In brief
“Genuine selective caspase-2 inhibition with new irreversible small peptidomimetics” is a 2022 journal article by Elodie Bosc and 19 co-authors, published in Cell Death and Disease. OpenAlex counts 17 citations as of 22 November 2026. It is open access under a CC BY licence: the full text is free to read at Cell Death and Disease.
- Citations
- 17
- Most cited in
- 2026 (7)
- Field-weighted impact
- 0.66
- References
- 50
- Authors
- 20
Abstract
Caspase-2 (Casp2) is a promising therapeutic target in several human diseases, including nonalcoholic steatohepatitis (NASH) and Alzheimer’s disease (AD). However, the design of an active-site-directed inhibitor selective to individual caspase family members is challenging because caspases have extremely similar active sites. Here we present new peptidomimetics derived from the VDVAD pentapeptide structure, harboring non-natural modifications at the P2 position and an irreversible warhead. Enzyme kinetics show that these new compounds, such as LJ2 or its specific isomers LJ2a, and LJ3a, strongly and irreversibly inhibit Casp2 with genuine selectivity. In agreement with the established role of Casp2 in cellular stress responses, LJ2 inhibits cell death induced by microtubule destabilization or hydroxamic acid-based deacetylase inhibition. The most potent peptidomimetic, LJ2a, inhibits human Casp2 with a remarkably high inactivation rate ( k 3 / K i ~5,500,000 M −1 s − 1 ), and the most selective inhibitor, LJ3a, has close to a 1000 times higher inactivation rate on Casp2 as compared to Casp3. Structural analysis of LJ3a shows that the spatial configuration of C α at the P2 position determines inhibitor efficacy. In transfected human cell lines overexpressing site-1 protease (S1P), sterol regulatory element-binding protein 2 (SREBP2) and Casp2, LJ2a and LJ3a fully inhibit Casp2-mediated S1P cleavage and thus SREBP2 activation, suggesting a potential to prevent NASH development. Furthermore, in primary hippocampal neurons treated with β-amyloid oligomers, submicromolar concentrations of LJ2a and of LJ3a prevent synapse loss, indicating a potential for further investigations in AD treatment.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Bosc, E., Anastasie, J., Soualmia, F., Coric, P., Kim, J. Y., Wang, L. Q., Lacin, G., Zhao, K., Patel, R., Duplus, E., Tixador, P., Sproul, A. A., Brugg, B., Reboud-Ravaux, M., Troy, C. M., Shelanski, M. L., Bouaziz, S., Karin, M., El Amri, C., & Jacotot, E. D. (2022). Genuine selective caspase-2 inhibition with new irreversible small peptidomimetics. Cell Death and Disease, 13(11), 959. https://doi.org/10.1038/s41419-022-05396-2
MLA 9
Bosc, Elodie, et al. “Genuine selective caspase-2 inhibition with new irreversible small peptidomimetics.” Cell Death and Disease, vol. 13, no. 11, 2022, p. 959. https://doi.org/10.1038/s41419-022-05396-2.
Chicago
Bosc, Elodie, Julie Anastasie, Feryel Soualmia, Pascale Coric, Ju Youn Kim, Lily Q. Wang, Gullen Lacin, et al. 2022. “Genuine selective caspase-2 inhibition with new irreversible small peptidomimetics.” Cell Death and Disease 13 (11): 959. https://doi.org/10.1038/s41419-022-05396-2.
Harvard
Bosc, E. et al. (2022) ‘Genuine selective caspase-2 inhibition with new irreversible small peptidomimetics’, Cell Death and Disease, 13(11), p. 959. doi:10.1038/s41419-022-05396-2.
IEEE
E. Bosc et al., “Genuine selective caspase-2 inhibition with new irreversible small peptidomimetics,” Cell Death and Disease, vol. 13, no. 11, p. 959, 2022, doi: 10.1038/s41419-022-05396-2.
BibTeX
@article{bosc2022genuine,
title = {{Genuine selective caspase-2 inhibition with new irreversible small peptidomimetics}},
author = {Bosc, Elodie and Anastasie, Julie and Soualmia, Feryel and Coric, Pascale and Kim, Ju Youn and Wang, Lily Q. and Lacin, Gullen and Zhao, Kaitao and Patel, Ronak and Duplus, Eric and Tixador, Philippe and Sproul, Andrew A. and Brugg, Bernard and Reboud-Ravaux, Michelle and Troy, Carol M. and Shelanski, Michael L. and Bouaziz, Serge and Karin, Michael and El Amri, Chahrazade and Jacotot, Etienne D.},
journal = {Cell Death and Disease},
year = {2022},
volume = {13},
number = {11},
pages = {959},
doi = {10.1038/s41419-022-05396-2},
url = {https://doi.org/10.1038/s41419-022-05396-2}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2023 | 1 | |
| 2024 | 4 | |
| 2025 | 5 | |
| 2026 | 7 |
Its field-weighted citation impact is 0.66: it has been cited 0.66 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- caspase-2
- site-1 protease
- nonalcoholic steatohepatitis
- Alzheimer's disease
- amyloid-beta oligomers
- hippocampal neurons
- synaptic loss
- microtubule destabilization
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Bosc, E., Anastasie, J., Soualmia, F., Coric, P., Kim, J. Y., Wang, L. Q., Lacin, G., Zhao, K., Patel, R., Duplus, E., Tixador, P., Sproul, A. A., Brugg, B., Reboud-Ravaux, M., Troy, C. M., Shelanski, M. L., Bouaziz, S., Karin, M., El Amri, C., & Jacotot, E. D. (2022). Genuine selective caspase-2 inhibition with new irreversible small peptidomimetics. Cell Death and Disease, 13(11), 959. https://doi.org/10.1038/s41419-022-05396-2
How many times has this paper been cited?
17 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Cell Death and Disease: sign in and open the PDF from this page.
Who wrote this paper?
Elodie Bosc, Julie Anastasie, Feryel Soualmia, Pascale Coric, Ju Youn Kim, Lily Q. Wang, Gullen Lacin, Kaitao Zhao, Ronak Patel, Eric Duplus, Philippe Tixador, Andrew A. Sproul and 8 more.
What is the DOI of this paper?
10.1038/s41419-022-05396-2, permanently at https://doi.org/10.1038/s41419-022-05396-2. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.